AU2001288564A1 - 5-hydroxytryptamine receptor gene polymorphisms and response to treatment - Google Patents

5-hydroxytryptamine receptor gene polymorphisms and response to treatment

Info

Publication number
AU2001288564A1
AU2001288564A1 AU2001288564A AU8856401A AU2001288564A1 AU 2001288564 A1 AU2001288564 A1 AU 2001288564A1 AU 2001288564 A AU2001288564 A AU 2001288564A AU 8856401 A AU8856401 A AU 8856401A AU 2001288564 A1 AU2001288564 A1 AU 2001288564A1
Authority
AU
Australia
Prior art keywords
response
treatment
receptor gene
gene polymorphisms
hydroxytryptamine receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288564A
Other languages
English (en)
Inventor
Kourtney J Davis
Mary Elizabeth Fling
Arlene R Hughes
Penelope Kupsinel Manasco
Michael James Stubbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001288564A1 publication Critical patent/AU2001288564A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001288564A 2000-09-06 2001-08-31 5-hydroxytryptamine receptor gene polymorphisms and response to treatment Abandoned AU2001288564A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23037800P 2000-09-06 2000-09-06
US60/230,378 2000-09-06
PCT/US2001/027066 WO2002020841A2 (fr) 2000-09-06 2001-08-31 Polymorphismes du gene du recepteur de la 5-hydroxytryptamine et reponse au traitement

Publications (1)

Publication Number Publication Date
AU2001288564A1 true AU2001288564A1 (en) 2002-03-22

Family

ID=22864991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288564A Abandoned AU2001288564A1 (en) 2000-09-06 2001-08-31 5-hydroxytryptamine receptor gene polymorphisms and response to treatment

Country Status (4)

Country Link
EP (1) EP1315837A2 (fr)
JP (1) JP2004508056A (fr)
AU (1) AU2001288564A1 (fr)
WO (1) WO2002020841A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
CN101448848B (zh) * 2006-03-27 2013-12-04 全球免疫股份有限公司 Ras突变及其相关组合物和方法
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2009060089A1 (fr) * 2007-11-09 2009-05-14 Universitätsklinikum Heidelberg Procédé de diagnostic et d'analyse de sous-groupe dans des sujets ayant ou étant suspectés d'avoir le syndrome du côlon irritable, acides nucléiques et kits, et leur utilisation
AU2010313292A1 (en) * 2009-10-30 2012-06-07 Nestec S.A. Methods for diagnosing irritable bowel syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
WO2002020841A3 (fr) 2002-09-19
JP2004508056A (ja) 2004-03-18
EP1315837A2 (fr) 2003-06-04
WO2002020841A2 (fr) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001238030A1 (en) Detection of single nucleotide polymorphisms
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2001245489A1 (en) Human single nucleotide polymorphisms
AU7119400A (en) Single nucleotide polymorphisms in genes
EP1434875A4 (fr) Polymorphismes geniques et reponse a un traitement
EP1144628A3 (fr) Gene de recepteur de vanilloide humain
AU2001288564A1 (en) 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
AU4050000A (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
AU2450001A (en) Detection of single nucleotide polymorphisms
AU2258601A (en) Ibd-related polymorphisms
AU2001253521A1 (en) Haplotypes of the cxcr4 gene
AU1773501A (en) Human single nucleotide polymorphisms
AU7500800A (en) Human fmo3 gene mutations and polymorphisms, and uses thereof
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2002324955A1 (en) Regulatory single nucleotide polymorphisms and methods therefor
AU2002249793A1 (en) Human single nucleotide polymorphisms
AU2002323055A1 (en) Gene polymorphisms and response to treatment
AU2001257020A1 (en) Haplotypes of the hsd3b1 gene
AU2001255330A1 (en) Haplotypes of the akr1b1 gene
AU2001270296A1 (en) Haplotypes of the mc2r gene
AU2001280483A1 (en) Haplotypes of the etfb gene
AU2001257050A1 (en) Haplotypes of the zfp36 gene
AU2001253367A1 (en) Haplotypes of the apoc1 gene
AU2001286807A1 (en) Haplotypes of the ifng gene
AU2001263307A1 (en) Haplotypes of the ccr3 gene